Provided by Tiger Trade Technology Pte. Ltd.

Cardiff Oncology, Inc.

1.31
+0.10008.26%
Pre-market: 1.29-0.0168-1.28%04:46 EDT
Volume:2.10M
Turnover:2.68M
Market Cap:101.75M
PE:-2.22
High:1.34
Open:1.23
Low:1.22
Close:1.21
52wk High:3.31
52wk Low:0.7566
Shares:77.67M
Float Shares:75.24M
Volume Ratio:3.38
T/O Rate:2.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5914
EPS(LYR):-0.6863
ROE:-94.08%
ROA:-46.73%
PB:3.84
PE(LYR):-1.91

Loading ...

Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS) and Cardiff Oncology (CRDF)

TIPRANKS
·
Yesterday

Cardiff Oncology - no Admission of Liability or Monetary Payment in Cardiff-Nerviano Settlement - SEC Filing

THOMSON REUTERS
·
Yesterday

Cardiff Oncology, Nerviano Settle Onvansertib Rights Lawsuit, Seek Dismissal with Prejudice

Reuters
·
Yesterday

Cardiff Oncology, - Co and Nms Agree to Full Mutual Release of All Claims in Litigation

THOMSON REUTERS
·
Yesterday

Cardiff Oncology and Nerviano Medical Sciences Amend Their 2017 Exclusive License Agreement

THOMSON REUTERS
·
Yesterday

Cardiff Oncology to Present at RAS-Targeted Drug Development Summit

Reuters
·
Sep 02

Cardiff Oncology Announces Special Shareholder Meeting

Reuters
·
Aug 27

Cardiff Oncology Announces Special Shareholder Meeting

Reuters
·
Aug 15

Replimune Q1 Net Loss Narrows as Expenses Decline

Reuters
·
Aug 14

Elicio Therapeutics Q2 Net Loss Narrows as R&D Expenses Fall

Reuters
·
Aug 14

PDS Biotechnology Q2 Net Loss Widens Slightly as Operating Costs Fall

Reuters
·
Aug 13

Pyxis Oncology Q2 Loss Widens on Increased Administrative Costs

Reuters
·
Aug 13

William Blair Downgrades Cardiff Oncology to Market Perform From Outperform

MT Newswires Live
·
Aug 12

Cardiff Oncology, Inc. : William Blair Cuts to Market Perform Rating

THOMSON REUTERS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Cardiff Oncology (CRDF)

TIPRANKS
·
Aug 12

William Blair downgrades Cardiff Oncology (CRDF) to a Hold

TIPRANKS
·
Aug 12

Cardiff Oncology Q2 EPS $(0.14) Beats $(0.16) Estimate, Sales $104.000K Beat $70.714K Estimate

Benzinga Earnings
·
Aug 12

Cardiff Oncology Q2 Operating Expenses Fall on Lower R&D Costs

Reuters
·
Aug 12

Cardiff Oncology Q2 Operating Expenses USD 9.719 Million

THOMSON REUTERS
·
Aug 12

Cardiff Oncology Q2 EPS USD -0.14

THOMSON REUTERS
·
Aug 12